BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1355374)

  • 1. Contact-induced neutrophil activation by platelets in human cell suspensions and whole blood.
    Ruf A; Schlenk RF; Maras A; Morgenstern E; Patscheke H
    Blood; 1992 Sep; 80(5):1238-46. PubMed ID: 1355374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-induced neutrophil activation: platelet-expressed fibrinogen induces the oxidative burst in neutrophils by an interaction with CD11C/CD18.
    Ruf A; Patscheke H
    Br J Haematol; 1995 Aug; 90(4):791-6. PubMed ID: 7669656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of leukocyte chemiluminescence by platelets: role of platelet-bound fibrinogen.
    Lösche W; Temmler U; Redlich H; Vickers J; Krause S; Spangenberg P
    Platelets; 2001 Feb; 12(1):15-9. PubMed ID: 11281625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin-activated platelets promote leukotriene B4 synthesis in polymorphonuclear leucocytes stimulated by physiological agonists.
    Palmantier R; Borgeat P
    Br J Pharmacol; 1991 Aug; 103(4):1909-16. PubMed ID: 1655146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of thrombin-degranulated human platelets: development of a method that does not use proteolytic enzymes for deaggregation.
    Kinlough-Rathbone RL; Packham MA; Guccione MA; Richardson M; Harfenist EJ; Mustard JF
    Thromb Haemost; 1991 Apr; 65(4):403-10. PubMed ID: 2057923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: the activity of cathepsin G is not prevented by antiproteinases.
    Evangelista V; Rajtar G; de Gaetano G; White JG; Cerletti C
    Blood; 1991 Jun; 77(11):2379-88. PubMed ID: 1645603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of platelet-leukocyte conjugates in whole blood.
    Redlich H; Vickers J; Lösche W; Heptinstall S; Kehrel B; Spangenberg P
    Platelets; 1997; 8(6):419-25. PubMed ID: 16793677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood platelets decrease concentration of reactive oxygen species produced by polymorphonuclear leukocytes.
    Jancinova V; Drabikova K; Petrikova M; Nosal R
    Bratisl Lek Listy; 2004; 105(7-8):250-5. PubMed ID: 15543845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist.
    Huang TF; Liu CZ; Ouyang CH; Teng CM
    Biochem Pharmacol; 1991 Aug; 42(6):1209-19. PubMed ID: 1888330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fibrinogen-derived peptide (RGDS) prevents proteolytic degradation of protein kinase C in platelets by inhibiting platelet aggregation.
    Krishnamurthi S; Dickens TA; Patel Y; Wheeler-Jones CP; Kakkar VV
    Biochem Biophys Res Commun; 1989 Sep; 163(3):1256-64. PubMed ID: 2783136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leucocyte activation by collagen-stimulated platelets in whole blood.
    Bengtsson T; Grenegård M
    Scand J Clin Lab Invest; 2002; 62(6):451-61. PubMed ID: 12469900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of oxygen metabolites from chemoattractant-stimulated neutrophils is inhibited by resting platelets: role of extracellular adenosine and actin polymerization.
    Bengtsson T; Zalavary S; Stendahl O; Grenegård M
    Blood; 1996 May; 87(10):4411-23. PubMed ID: 8639803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation.
    Chow TW; Hellums JD; Moake JL; Kroll MH
    Blood; 1992 Jul; 80(1):113-20. PubMed ID: 1611079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the cell adhesion peptide, Arg-Gly-Asp-Ser, on responses of washed platelets from humans, rabbits, and rats.
    Harfenist EJ; Packham MA; Mustard JF
    Blood; 1988 Jan; 71(1):132-6. PubMed ID: 3334894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of platelet function by polymorphonuclear leukocytes.
    Zatta A; Prosdocimi M; Bertelé V; Bazzoni G; Del Maschio A
    J Lab Clin Med; 1990 Nov; 116(5):651-60. PubMed ID: 2146349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adhesion of activated platelets to polymorphonuclear leukocytes.
    Spangenberg P
    Thromb Res; 1994; 74 Suppl 1():S35-44. PubMed ID: 7521070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of intravascular neutrophil chemotactic factors on blood neutrophil and platelet kinetics.
    Issekutz AC; Ripley M
    Am J Hematol; 1986 Feb; 21(2):157-71. PubMed ID: 2934975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboxane A2 causes feedback amplification involving extensive thromboxane A2 formation on close contact of human platelets in media with a low concentration of ionized calcium.
    Packham MA; Kinlough-Rathbone RL; Mustard JF
    Blood; 1987 Sep; 70(3):647-51. PubMed ID: 3620698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-dependent modulation of polymorphonuclear leukocyte chemiluminescence.
    Jancinová V; Drábiková K; Nosál R; Danihelová E
    Platelets; 2000 Aug; 11(5):278-85. PubMed ID: 11030462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet enhancement of O2-. responses in stimulated human neutrophils. Identification of platelet factor as adenine nucleotide.
    Ward PA; Cunningham TW; McCulloch KK; Phan SH; Powell J; Johnson KJ
    Lab Invest; 1988 Jan; 58(1):37-47. PubMed ID: 2826882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.